Author:
Wang Jie,Huang Hongxin,Liu Yongzhen,Chen Ran,Yan Ying,Shi Shu,Xi Jingyuan,Zou Jun,Yu Guangxin,Feng Xiaoyu,Lu Fengmin
Reference191 articles.
1. GBD (2018) Causes of death collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the global burden of disease study 2017. Lancet 392(10159):1736–1788
2. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ (2015) Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 386(10003):1546–1555
3. World Health Organization. Hepatitis B 2018 [Available from: http://www.who.int/news-room/fact-sheets/detail/hepatitis-b ]
4. Lau GK, Piratvisuth T, Luo KX, Marcellin P, Thongsawat S, Cooksley G et al (2005) Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N Engl J Med 352(26):2682–2695
5. Wei L, Kao JH (2017) Benefits of long-term therapy with nucleos(t)ide analogues in treatment-naïve patients with chronic hepatitis B. Curr Med Res Opin 33(3):495–504
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献